1. Home
  2. GKOS vs TX Comparison

GKOS vs TX Comparison

Compare GKOS & TX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$168.70

Market Cap

10.6B

Sector

Health Care

ML Signal

N/A

Logo Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

TX

Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

N/A

Current Price

$57.46

Market Cap

10.9B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
GKOS
TX
Founded
1998
1961
Country
United States
Luxembourg
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.6B
10.9B
IPO Year
2015
2006

Fundamental Metrics

Financial Performance
Metric
GKOS
TX
Price
$168.70
$57.46
Analyst Decision
Strong Buy
Hold
Analyst Count
12
5
Target Price
$126.92
$37.70
AVG Volume (30 Days)
573.4K
505.6K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
N/A
6.31%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$507,442,000.00
N/A
Revenue This Year
$23.32
$9.60
Revenue Next Year
$27.43
$6.66
P/E Ratio
N/A
$20.15
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$33.01
52 Week High
$191.62
$58.73

Technical Indicators

Market Signals
Indicator
GKOS
TX
Relative Strength Index (RSI) 45.52 61.58
Support Level $96.44 $53.41
Resistance Level $184.68 $58.49
Average True Range (ATR) 6.22 1.34
MACD -2.25 -0.22
Stochastic Oscillator 31.38 69.17

Price Performance

Historical Comparison
GKOS
TX

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel and Mining. In its Steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The vast majority of its revenue comes from the Steel segment and geographically from Mexico.

Share on Social Networks: